Study of inflammation patterns in chronic skin diseases
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This study looks at molecular (body-level) signatures in people with chronic inflammatory skin conditions. You may help researchers understand what drives inflammation, while receiving standard (already approved) systemic treatment through routine care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can read and sign a consent form and follow the study plan
- A dermatologist has diagnosed you with a long-term inflammatory skin condition
- You are currently using a systemic treatment as part of routine care (like an approved biologic)
- You have NOT used immunosuppressing or immune-changing medicines in the last 4 weeks
- You have NOT had recent light therapy (phototherapy) in the last 4 weeks
- You have NOT applied topical steroid or topical calcineurin-inhibitor to the study skin areas in the last week
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what affects the “path” (trajectory) of long-lasting inflammatory skin conditions. It may help researchers understand why symptoms change and how treatments or factors influence those changes.
This study looks at how atopic dermatitis (eczema), psoriasis, or other autoimmune skin diseases change over time and how the body responds to anti-inflammatory signals. Your information and—if eligible—samples help researchers find patterns that could guide better treatments.
This study looks for clues in your skin and blood that could predict how well you'll respond to treatments for conditions like eczema, psoriasis, or lupus. It aims to help doctors choose the best therapy for you.
This study looks at what’s happening inside the body in people with plaque psoriasis who start certain biologic medicines that target the IL-23/IL-17 immune pathway. It may help explain why these treatments work and what body changes are linked to response.
This study looks at the immune cells in skin samples from people with psoriasis who are being treated with an anti-IL-23 biologic. The goal is to understand why some areas of skin do not improve or why flares happen, which may help improve treatments.
This study looks at how inflammation-related genes behave in people with psoriasis. It may help researchers understand why psoriasis flares and how it could be better treated.
Hear when a new Atopic Dermatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.